Rosiglitazone Does Not Harm Bone Healing If Combined With Metformin In Rats
Taking the diabetes medications metformin and rosiglitazone together reverses the adverse effects on bone of rosiglitazone treatment alone in an experimental model, according to a new study done in rats. The results were presented at The Endocrine Society’s 91st Annual Meeting in Washington, D.C.
More: continued here
Filed under: Bones on June 19th, 2009
You must be logged in to post a comment.